Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Natural products in dermatology

Sep. 13, 2007

Less toxicity seen with ISA-247 than with ciclosporin in vitro

Sep. 13, 2007

Experiments reveal characteristics of GA2-50, a possible treatment for cocaine abuse

Sep. 13, 2007

Positive first-in-human trial results of novel endothelin antagonist from Actelion

Sep. 12, 2007

IL-22 blockade shows benefit in mouse model of rheumatoid arthritis

Sep. 12, 2007

Antiinflammatory effects of the GABA-B agonist baclofen shown in mice

Sep. 12, 2007

C-reactive protein, neopterin correlate with PRTX-100 dose in healthy subjects

Sep. 12, 2007

Pharmacokinetics of GSK-221149A studied to prepare for clinical trial

Sep. 12, 2007

Studies advance clinical development of almorexant for insomnia

Sep. 10, 2007

PAR-1 inhibition by SCH-602539 shows antithrombotic effects in vivo

Sep. 10, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...